These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. Porter B; Arthur A; Savva GM BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652 [TBL] [Abstract][Full Text] [Related]
4. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study. Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916 [TBL] [Abstract][Full Text] [Related]
5. Polypharmacy is associated with frailty in Japanese community-dwelling older adults. Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240 [TBL] [Abstract][Full Text] [Related]
6. Association Between Serum β Kim M; Suzuki T; Kojima N; Yoshida H; Yoshida Y; Hirano H; Won CW; Kim H J Am Geriatr Soc; 2017 Apr; 65(4):e83-e88. PubMed ID: 28140452 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study. Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180 [TBL] [Abstract][Full Text] [Related]
8. Is Polypharmacy Associated with Cognitive Frailty in the Elderly? Results from the Korean Frailty and Aging Cohort Study. Moon JH; Huh JS; Won CW; Kim HJ J Nutr Health Aging; 2019; 23(10):958-965. PubMed ID: 31781725 [TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Herr M; Robine JM; Pinot J; Arvieu JJ; Ankri J Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):637-46. PubMed ID: 25858336 [TBL] [Abstract][Full Text] [Related]
10. Relationship between frailty, polypharmacy, and underprescription in older adults living in nursing homes. Gutiérrez-Valencia M; Izquierdo M; Lacalle-Fabo E; Marín-Epelde I; Ramón-Espinoza MF; Domene-Domene T; Casas-Herrero Á; Galbete A; Martínez-Velilla N Eur J Clin Pharmacol; 2018 Jul; 74(7):961-970. PubMed ID: 29589065 [TBL] [Abstract][Full Text] [Related]
11. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study. Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661 [TBL] [Abstract][Full Text] [Related]
12. Frailty and mortality or incident disability in institutionalized older adults: the FINAL study. de la Rica-Escuín M; González-Vaca J; Varela-Pérez R; Arjonilla-García MD; Silva-Iglesias M; Oliver-Carbonell JL; Abizanda P Maturitas; 2014 Aug; 78(4):329-34. PubMed ID: 24929996 [TBL] [Abstract][Full Text] [Related]
13. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. Nishiguchi S; Yamada M; Fukutani N; Adachi D; Tashiro Y; Hotta T; Morino S; Shirooka H; Nozaki Y; Hirata H; Yamaguchi M; Arai H; Tsuboyama T; Aoyama T J Am Med Dir Assoc; 2015 Feb; 16(2):120-4. PubMed ID: 25244957 [TBL] [Abstract][Full Text] [Related]
14. Investigation of a possible association of potentially inappropriate medication for older adults and frailty in a prospective cohort study from Germany. Muhlack DC; Hoppe LK; Saum KU; Haefeli WE; Brenner H; Schöttker B Age Ageing; 2019 Dec; 49(1):20-25. PubMed ID: 31732737 [TBL] [Abstract][Full Text] [Related]
15. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies. Mijnarends DM; Schols JM; Meijers JM; Tan FE; Verlaan S; Luiking YC; Morley JE; Halfens RJ J Am Med Dir Assoc; 2015 Apr; 16(4):301-8. PubMed ID: 25530211 [TBL] [Abstract][Full Text] [Related]
16. Polypharmacy and Incident Frailty in a Longitudinal Community-Based Cohort Study. Shmuel S; Lund JL; Alvarez C; Hsu CD; Palta P; Kucharska-Newton A; Jordan JM; Nelson AE; Golightly YM J Am Geriatr Soc; 2019 Dec; 67(12):2482-2489. PubMed ID: 31648378 [TBL] [Abstract][Full Text] [Related]
17. Changes in frailty status in a community-dwelling cohort of older adults: The VERISAÚDE study. Lorenzo-López L; López-López R; Maseda A; Buján A; Rodríguez-Villamil JL; Millán-Calenti JC Maturitas; 2019 Jan; 119():54-60. PubMed ID: 30502751 [TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a modification of the Fried frailty criteria using population-independent cutpoints. Saum KU; Müller H; Stegmaier C; Hauer K; Raum E; Brenner H J Am Geriatr Soc; 2012 Nov; 60(11):2110-5. PubMed ID: 23043490 [TBL] [Abstract][Full Text] [Related]
19. Associations of frailty with health care costs--results of the ESTHER cohort study. Bock JO; König HH; Brenner H; Haefeli WE; Quinzler R; Matschinger H; Saum KU; Schöttker B; Heider D BMC Health Serv Res; 2016 Apr; 16():128. PubMed ID: 27074800 [TBL] [Abstract][Full Text] [Related]
20. Association Between Potentially Inappropriate Medications and Frailty in the Early Old Age: A Longitudinal Study in the GAZEL Cohort. Martinot P; Landré B; Zins M; Goldberg M; Ankri J; Herr M J Am Med Dir Assoc; 2018 Nov; 19(11):967-973.e3. PubMed ID: 30172683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]